These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 639833)

  • 1. Bioavailability of p-chlorophenoxyisobutyric acid (clofibrinic acid) after repeated doses of its calcium salt to humans.
    Taylor T; Chasseaud LF; Darragh A; O'Kelly DA
    Eur J Clin Pharmacol; 1978 Mar; 13(1):49-53. PubMed ID: 639833
    [No Abstract]   [Full Text] [Related]  

  • 2. [A quantitative gaschromatographic method for the determination of p-chlorophenoxyisobutyric acid (clofibrinic acid) in human plasma (author's transl)].
    Häselbarth V
    Arzneimittelforschung; 1976; 26(11):2076-80. PubMed ID: 1037251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-pressure liquid chromatographic analysis of drugs in biological fluids. IV. Determination of clofibrinic acid.
    Bjornsson TD; Blaschke TF; Meffin PJ
    J Chromatogr; 1977 Jul; 137(1):145-52. PubMed ID: 893579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations and bioavailability of clofibric acid from its calcium salt in humans.
    Taylor T; Chasseaud LF
    J Pharm Sci; 1977 Nov; 66(11):1638-9. PubMed ID: 915750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative bioavailability of etofibrate. A comparison of an acute and a new sustained release formulation.
    Johnson KI; Hoppe HJ; Schatton W
    Arzneimittelforschung; 1984; 34(12):1785-7. PubMed ID: 6543315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rapid gas chromatographic method for the determination of chlorophenoxyisobutyric acid in plasma and urine.
    Gugler R; Jensen C
    J Chromatogr; 1976 Feb; 117(1):175-9. PubMed ID: 1249148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of colestipol hydrochloride on the bioavailability and pharmacokinetics of clofibrate.
    DeSante KA; DiSanto AR; Albert KS; Weber DJ; Welch RD; Vecchio TJ
    J Clin Pharmacol; 1979; 19(11-12):721-5. PubMed ID: 536468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative gas chromatographic determination of clofibrinic acid in plasma.
    Berlin A
    J Pharm Pharmacol; 1975 Jan; 27(1):54-5. PubMed ID: 235619
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacokinetic study in man of hypolipemic agents derived from clofibric acid after single and repeated administration].
    Cailleux A; Allain P; Tadei A
    Therapie; 1976; 31(5):637-45. PubMed ID: 1013956
    [No Abstract]   [Full Text] [Related]  

  • 10. Clofibrate and enzymatic induction in man.
    Houin G; Tillement JP
    Int J Clin Pharmacol Biopharm; 1978 Apr; 16(4):150-4. PubMed ID: 649234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic study and bioavailability of three marketed compounds releasing p-chlorophenoxyisobutyric acid (CPIB) in volunteers.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Biopharm; 1976 Sep; 14(2):113-8. PubMed ID: 1002348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of p-chlorophenoxyisobutyric acid in blood plasma by gas-liquid chromatography.
    Cuong TC; Tuong A
    J Chromatogr; 1975 Mar; 106(1):97-102. PubMed ID: 239014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma clofibric acid (CPIB) levels induced by three marketed compounds releasing clofibric acid, in volunteers.
    Harvengt C; Desager JP
    Int J Clin Pharmacol Biopharm; 1977 Jan; 15(1):1-4. PubMed ID: 576423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioavailability studies of etofibrate in rhesus monkeys.
    Waller AR; Chasseaud LF; Taylor T; Schatton W
    Arzneimittelforschung; 1985; 35(2):489-92. PubMed ID: 4039571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A gas-liquid chromatographic determination of p-chlorophenoxyisobutyric acid and its comparison to an ultra violet method.
    Bruderlein H; Robinson WT; Kraml M; Dvornik D
    Clin Biochem; 1975 Aug; 8(4):261-72. PubMed ID: 1157294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to plasma lipoproteins of chlorophenoxyisobutyric, tibric and nicotinic acids and their esters.
    Beaumont JL; Dachet C
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):41-3. PubMed ID: 1019153
    [No Abstract]   [Full Text] [Related]  

  • 17. Quantitative gas-chromatographic flame-ionization method for p-chlorophenoxyisobutyric acid in human serum and saliva.
    Connor JN; Johnson GF; Solomon HM
    Clin Chem; 1976 Jun; 22(6):884-8. PubMed ID: 1277477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetic behavior of clofibrate in patients with kidney insufficiency].
    Hartlapp J; Kürten J; Klehr U; Gugler R
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1709-11. PubMed ID: 611915
    [No Abstract]   [Full Text] [Related]  

  • 19. Saliva and plasma levels and plasma protein binding of clofibrinic acid in uremic patients.
    Bjornsson TD; Meffin PJ; Peters FA; Blaschke TF
    Clin Pharmacol Ther; 1980 Feb; 27(2):230-5. PubMed ID: 7353345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steady-state kinetics of bezafibrate and clofibrate in healthy female volunteers.
    Abshagen U; Spörl-Radun S; Marinow J
    Eur J Clin Pharmacol; 1980 Apr; 17(4):305-8. PubMed ID: 6995131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.